Literature DB >> 21042016

Time is like a clock in my heart: implications for stem cell delivery after myocardial infarction.

John A Schoenhard, Antonis K Hatzopoulos.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21042016      PMCID： PMC2992645          DOI： 10.1159/000321396

Source DB:  PubMed          Journal:  Cardiology        ISSN： 0008-6312            Impact factor:   1.869


× No keyword cloud information.
  15 in total

Review 1.  Stem cell therapy for myocardial infarction: are we missing time?

Authors:  Kasper W ter Horst
Journal:  Cardiology       Date:  2010-09-29       Impact factor: 1.869

2.  Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Y Wang; H E Johnsen; S Mortensen; L Bindslev; R Sejersten Ripa; M Haack-Sørensen; E Jørgensen; W Fang; J Kastrup
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

3.  Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction.

Authors:  Jun Ma; Junbo Ge; Shaoheng Zhang; Aijun Sun; Jianying Shen; Leilei Chen; Keqiang Wang; Yunzeng Zou
Journal:  Basic Res Cardiol       Date:  2005-03-10       Impact factor: 17.165

4.  SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.

Authors:  Ming Zhang; Niladri Mal; Matthew Kiedrowski; Matthews Chacko; Arman T Askari; Zoran B Popovic; Omer N Koc; Marc S Penn
Journal:  FASEB J       Date:  2007-05-11       Impact factor: 5.191

5.  Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.

Authors:  Jay H Traverse; Timothy D Henry; Douglas E Vaughan; Douglas E Vaughn; Stephen G Ellis; Carl J Pepine; James T Willerson; David X M Zhao; Linda B Piller; Marc S Penn; Barry J Byrne; Emerson C Perin; Adrian P Gee; Antonis K Hatzopoulos; David H McKenna; John R Forder; Doris A Taylor; Christopher R Cogle; Rachel E Olson; Beth C Jorgenson; Shelly L Sayre; Rachel W Vojvodic; David J Gordon; Sonia I Skarlatos; Lemuel A Moye'; Robert D Simari
Journal:  Am Heart J       Date:  2009-07-23       Impact factor: 4.749

6.  Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection.

Authors:  Rabea Hinkel; Chiraz El-Aouni; Tonia Olson; Jan Horstkotte; Stefan Mayer; Sebastian Müller; Michael Willhauck; Christine Spitzweg; Franz-Josef Gildehaus; Wolfgang Münzing; Ewald Hannappel; Ildiko Bock-Marquette; J Michael DiMaio; Antonis K Hatzopoulos; Peter Boekstegers; Christian Kupatt
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

Review 7.  Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials.

Authors:  Shuning Zhang; Aijun Sun; Danling Xu; Kang Yao; Zheyong Huang; Huan Jin; Keqiang Wang; Yunzeng Zou; Junbo Ge
Journal:  Clin Cardiol       Date:  2009-08       Impact factor: 2.882

Review 8.  Stem cell therapy for cardiac repair: benefits and barriers.

Authors:  Steven J Joggerst; Antonis K Hatzopoulos
Journal:  Expert Rev Mol Med       Date:  2009-07-08       Impact factor: 5.600

Review 9.  Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease.

Authors:  Konstantinos D Boudoulas; Antonis K Hatzopoulos
Journal:  Dis Model Mech       Date:  2009 Jul-Aug       Impact factor: 5.758

10.  Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance.

Authors:  Zhaokang Cheng; Lailiang Ou; Xin Zhou; Fei Li; Xiaohua Jia; Yinguo Zhang; Xiaolei Liu; Yuming Li; Christopher A Ward; Luis G Melo; Deling Kong
Journal:  Mol Ther       Date:  2008-02-05       Impact factor: 11.454
View more
  1 in total

1.  Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.

Authors:  Bo Tao; Mingliang Cui; Chen Wang; Sai Ma; Feng Wu; Fu Yi; Xing Qin; Junting Liu; Haichang Wang; Zhe Wang; Xiaowei Ma; Jie Tian; Yundai Chen; Jing Wang; Feng Cao
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.